Tag Archives: Randomized controlled trial

Industry and FDA Brace for Change

While the convention floor of the 46th annual meeting of the Drug Information Association bustled with the usual vendors touting the latest and greatest clinical trial technology, the panels (particularly those that featured FDA members) had a remarkably somber tone. The main refrain was: “Things are going to change and everyone must step up or […]
Posted in Regulatory, Strategy | Also tagged , , , , , | 1 Comment
  • Categories

  • Meta